The Global interventional neurology market is expected to grow at an approximate CAGR of 7.8% during forecast period. Increasing participation of market players is the key factor driving the interventional neurology market. For instance, in 2018, Rapid Medical announced CE Mark approval in the European Union for its Tigertriever 13 stent retriever for the treatment of ischemic...